Chemed Corporation (CHE)
| Market Cap | 8.72B |
| Revenue (ttm) | 2.07B |
| Net Income (ttm) | 271.29M |
| Shares Out | 15.94M |
| EPS (ttm) | 16.49 |
| PE Ratio | 33.25 |
| Forward PE | 28.25 |
| Dividend | $1.36 |
| Dividend Yield | 0.25% |
| Trading Day | January 22 |
| Last Price | $548.17 |
| Previous Close | $545.21 |
| Change ($) | 2.96 |
| Change (%) | 0.54% |
| Day's Open | 542.56 |
| Day's Range | 539.07 - 554.08 |
| Day's Volume | 59,363 |
| 52-Week Range | 350.85 - 554.08 |
3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn
Final Trades: CVS, Gold, Chemed & more
The "Halftime Report" traders give their top picks to watch for the second half.
The sale of Uber Elevate may recoup some of the losses suffered in the effort to build a marketable air taxi
Chemed (CHE) possesses solid growth attributes, which could help it handily outperform the market.
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Many investors believe that financial markets react to the news. But it's a bit more nuanced than that.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-cents per share on the Company's capital sto...
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Credit Suisse 29th Annual Virtual Healthcare Conference on Tuesday, Novemb...
Chemed (CHE) could produce exceptional returns because of its solid growth attributes.
Chemed (CHE) reports solid revenue growth across key subsidiaries in third-quarter results.
Chemed Corporation (CHE) CEO Kevin McNamara on Q3 2020 Results - Earnings Call Transcript
Chemed (CHE) delivered earnings and revenue surprises of 21.80% and 2.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Chemed (NYSE:CHE) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 40.46% year over year to $4.86, which beat the...
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Ro...
Coronavirus is going to affect the earnings results of healthcare players. While hospitals and health insurers might have suffered the COVID-19 impact, others providing virtual care and COVID-...
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2020, on Thursday, October 29, 2020,...
Nervous investors are bracing for a rough trading day amid news that President Trump and the first lady tested positive for COVID-19. Furthermore, markets faced additional headwinds based on t...
As the world grapples with an unprecedented coronavirus pandemic, five health care stocks that have outperformed the Standard & Poor's 500 Index by at least 5% in the year to date are Amerisou...
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Markets are looking for some direction today with the Dow lower, the S&P flat, and the Nasdaq higher. Some optimism is shown on the economic side today with durable goods orders rising 11.2% i...
Chemed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Stocks Generating Improved Relative Strength: Chemed appeared first on Investor's Busine...
Amid the pandemic scenario, Chemed's (CHE) VITAS and Roto-Rooter both have been classified as essential services.
Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2020 Results - Earnings Call Transcript
Consumer sentiment continues to slide as the count of coronavirus cases keeps increasing in the U.S., putting the economic recovery in doubt.
Chemed (CHE) witnesses solid revenue growth across key subsidiaries in Q2 earnings.
Chemed (CHE) delivered earnings and revenue surprises of 16.36% and -1.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-R...
Chemed (NYSE:CHE) unveils its next round of earnings this Wednesday, July 29. Get prepared with Benzinga's ultimate preview for Chemed's Q2 earnings.
After a brief recovery in the early hours, all major indices are currently trading in the red. The rising COVID cases and a debated stimulus package could determine how markets behave in the w...
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed To Report Second-Quarter 2020 Earnings July 29, Related Conference Call To Be Held On July 30
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2020, on Wednesday, July 29, 2020, follo...
In the latest trading session, Chemed (CHE) closed at $467.36, marking a +1.62% move from the previous day.
Chemed (CHE) closed the most recent trading day at $456.01, moving +1.3% from the previous trading session.
“The greatest companies in lousy industries share certain characteristics. They are low-cost operators and penny-pinchers in the executive suite.
Chemed (CHE) closed at $456.38 in the latest trading session, marking a +0.92% move from the prior day.
Debt financing is a feasible option as long as the companies succeed in generating a higher rate of return compared to the interest rate
Chemed (CHE) closed at $478.51 in the latest trading session, marking a -0.78% move from the prior day.
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Investors continue to be optimistic about Chemed (CHE) on robust segmental growth.
There are approximately 35 million Americans aged 65 or older currently and this number is expected to double in the next 25 years.
Is (CHE) Outperforming Other Medical Stocks This Year?
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemed Corporation (CHE) CEO Kevin McNamara on Q1 2020 Results - Earnings Call Transcript
About CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. The company was incorporated in 1970 and is headquartered in Cincin... [Read more...]
| Industry Medical Care Facilities | |
| CEO Kevin McNamara | Employees 16,641 |
| Stock Exchange NYSE | Ticker Symbol CHE |
Financial Performance
In 2019, Chemed's revenue was $1.94 billion, an increase of 8.75% compared to the previous year's $1.78 billion. Earnings were $219.92 million, an increase of 7.00%.
Analyst Forecasts
According to 3 analysts, the average rating for Chemed stock is "Strong Buy." The 12-month stock price forecast is 580.00, which is an increase of 5.81% from the latest price.